SHBG and fatty liver disease: In model 1, markers of liverfibrosis (FIB-4 and NFS respectively), diabetes duration, sex, pO2, GGT,ferritin, C-peptide and SHBG were used as independent variables, in model 2 BFMwas added (as these parameters were identified as significantly correlated withEATT in the bivariate analyses), while in model 3 a full adjustment was done withwaist, HbA1c and HOMA-IR (instead of C-peptide) added as independent variables.The same was done for the markers of liver steatosis (FLI and HSI, respectively),except that ASAT was used instead of GGT.